Avalo Therapeutics Inc
NASDAQ:AVTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
B
|
Blue Label Telecoms Ltd
JSE:BLU
|
ZA |
|
Baozun Inc
F:2BZ
|
CN |
|
T
|
Terreno Realty Corp
F:T37
|
US |
|
S
|
Snap-On Inc
DUS:SPU
|
US |
|
Kingsoft Cloud Holdings Ltd
NASDAQ:KC
|
CN |
|
CF Bankshares Inc
NASDAQ:CFBK
|
US |
|
InPost SA
AEX:INPST
|
LU |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XMUN:MUV2
|
DE |
|
S
|
Sega Sammy Holdings Inc
SWB:RYU
|
JP |
|
St Dupont SA
F:7EK
|
FR |
|
Daito Bank Ltd
TSE:8563
|
JP |
|
Selvaag Bolig ASA
OSE:SBO
|
NO |
|
Condor Energies Inc
TSX:CDR
|
CA |
Wall St Price Targets
AVTX Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AVTX is 47.11 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVTX's stock price target?
Price Target
47.11
USD
According to Wall Street analysts, the average 1-year price target for AVTX is 47.11 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.
What is the Gross Profit forecast for Avalo Therapeutics Inc?
Projected CAGR
221%
The compound annual growth rate for Gross Profit over the next 8 years is 221%.
